1. 4CPS-143 Evaluation of knowledge of patients with inflammatory bowel disease treated by the reference product concerning biosimilars: role of clinical pharmacists. (March 2019) Authors: Coget, E; Laffont-Lozes, P; Velasco Gonzalvo, V; Huc, D; Pineton de Chambrun, G; Altwegg, R; Blanc, P; Pageaux, GP; Rosant, D; Breuker, C Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-144 Establishment of a pharmaceutical standardised interview concerning biosimilars of infliximab in the daycare clinic of a gastroenterology department for patients affected by inflammatory bowel disease. (March 2019) Authors: Coget, E; Laffont-Lozes, P; Velasco Gonzalvo, V; Huc, D; Pineton de Chambrun, G; Altwegg, R; Blanc, P; Pageaux, GP; Rosant, D; Breuker, C Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study. (5th May 2022) Authors: Poullenot, F; Amiot, A; Nachury, M; Viennot, S; Altwegg, R; Bouhnik, Y; Abitbol, V; Nancey, S; Vuitton, L; Peyrin-Biroulet, L; Biron, A; Fumery, M; Picon, L; Vidon, M; Reenaers, C; Serrero, M; Savoye, G; Beaugerie, L; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 10(2022) Page Start: 1523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP36 Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter study. (21st January 2022) Authors: Sallette, M; Bouhnik, Y; Nachury, M; Bellanger, C; Laharie, D; Amiot, A; Peyrin-Biroulet, L; Roblin, X; Altwegg, R; Buisson, A; Reenaers, C; Bouguen, G; Vuitton, L; Bourreille, A; Gilletta, C; Serrero, M; Hébuterne, X; Filippi, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP63 Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent. (21st January 2022) Authors: Buisson, A; Nachury, M; Fumery, M; Guilmoteau, T; Leclerc, E; Altwegg, R; Serrero, M; Mathieu, N; Treton, X; Vuitton, L; Pereira, B; Amiot, A; Bouguen, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP89 Impact of biologics on the risk of early postoperative complications in Crohn's disease: a French nationwide study. (30th January 2023) Authors: Fumery, M; Nancey, S; Nachury, M; Allez, M; Rouillon, C; Boureille, A; Altwegg, R; Serrero, M; Vuitton, L; Bouguen, G; Abitbol, V; Boualit, M; Biron, A; Panis, Y; Laharie, D; Amiot, A; Simon, M; Caillo, L; Hébuterne, X; Vidon, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study. (26th February 2022) Authors: Cottron, C; Treton, X; Altwegg, R; Reenaers, C; Amiot, A; Fumery, M; Vuitton, L; Peyrin-Biroulet, L; Bouguen, G; Dewit, O; Nancey, S; Caillo, L; Roblin, X; Beylot-Barry, M; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 8(2022) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]. (24th September 2020) Authors: Moreau, J; Hammoudi, N; Marthey, L; Trang-Poisson, C; Nachury, M; Altwegg, R; Grimaud, J C; Orempuller, S; Hébuterne, X; Aubourg, A; Baudry, C; Seksik, P; Roblin, X; Nahon, S; Savoye, G; Mesnard, B; Stefanescu, C; Simon, M; Coffin, B; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 3(2021) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗